News Industry News NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin® April 20, 2016
News Industry News Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems August 24, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015
News Industry News Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat May 26, 2015